LGD-3303.

Quick Overview.

LGD-3303 is a highly potent, non-steroidal Selective Androgen Receptor Modulator (SARM) developed by Ligand Pharmaceuticals. While it shares the "LGD" prefix with the much more famous LGD-4033 (Ligandrol), it is a distinctly different compound with a completely different cosmetic effect on the body.[1]

If LGD-4033 is known for "wet" mass (causing water retention and a bulky look), LGD-3303 is known for "dry" mass. In the bodybuilding community, it is often compared to RAD-140 or even the oral steroid Winstrol. It produces rapid increases in strength, significant muscle fullness, and a very dry, vascular appearance. However, because it never progressed past preclinical animal trials, it is one of the least studied SARMs in human beings.[2]

• Primary Use Case: Dry muscle mass, extreme strength gains, and pre-contest hardening.
• Mechanism: Highly selective agonism of the androgen receptor in skeletal muscle and bone.[3]
• Who it is for: Advanced researchers looking for a dry alternative to LGD-4033 who are comfortable using a compound with zero human clinical data.
• Who it is NOT for: Beginners, women, or anyone looking for a well-researched, clinically validated compound.

The Protocol & Usage Guide.

confidence_tier: community

Note: Because LGD-3303 never entered human clinical trials, all dosing protocols are derived entirely from anecdotal community reports and extrapolations from animal models.

LGD-3303 has a very short half-life, estimated to be around 6 hours. Therefore, it must be dosed multiple times per day to maintain stable blood serum levels.[4]

Standard Dosing Schedule

Cycle Length & Discontinuation Protocol

• Cycle Length: 6 to 8 weeks. Do not exceed 8 weeks due to the lack of long-term safety data and the known hepatotoxicity of oral SARMs.
• Discontinuation (PCT): LGD-3303 is highly suppressive to the HPG axis. A full Post Cycle Therapy (PCT) using Enclomiphene (12.5mg daily for 4 weeks) or Nolvadex (20mg daily for 4 weeks) is absolutely mandatory.

Nutritional Support & Recommended Supplements.

confidence_tier: community

Safety, Interactions & Side Effect Management.

confidence_tier: community

Side Effect Profile

Contraindications

• Absolute: Individuals with pre-existing liver disease or severe cardiovascular issues.
• Absolute: Teenagers whose endocrine systems are still developing.
• Relative: Women, due to the unknown but likely high risk of virilization.

Drug Interactions

• Alcohol: Severe. Combining oral SARMs with alcohol places immense stress on the liver.
• Accutane / Hepatotoxic Drugs: Severe. Do not stack with other liver-toxic medications.

Common Stacks & Combinations.

confidence_tier: community

Body Composition & Training Guide.

confidence_tier: community

• The "Dry" LGD: The most common community feedback regarding LGD-3303 is how different it feels from LGD-4033. Users report zero water retention. The muscle gained is highly visible, dense, and vascular.
• Muscle Fullness: Despite being a "dry" compound, LGD-3303 is famous for causing extreme muscle fullness (glycogen retention within the muscle belly), giving users a "pumped" look even when they are not training.
• Strength Gains: Anecdotally, the strength gains from LGD-3303 rival those of RAD-140, making it a favorite among powerlifters looking to stay within a specific weight class (since it doesn't add water weight).

Storage, Handling & Accessibility.

confidence_tier: well-established

• Storage: Store liquid solutions or capsules at room temperature in a cool, dark place.
• WADA Status: Banned in competitive sports under section S1.2 (Other Anabolic Agents).
• Cost & Accessibility: Less common than LGD-4033 or Ostarine, but still available from specialized research chemical vendors. Typically costs $60-$80 for a 30mL bottle.

Bloodwork Monitoring Guide.

confidence_tier: well-established

Comparison to Similar Compounds.

confidence_tier: community

Deep Dive (For Advanced Researchers).

confidence_tier: well-established

Mechanism of Action

LGD-3303 is a non-steroidal selective androgen receptor modulator. It binds to the androgen receptor (AR) with high affinity and acts as a full agonist in skeletal muscle and bone. In preclinical rat models, it demonstrated a classic SARM profile: it significantly increased the weight of the levator ani muscle (a marker of anabolic activity) while only partially stimulating the prostate (a marker of androgenic activity).[5]

Preclinical Efficacy (Animal Models)

Because LGD-3303 never entered human trials, all scientific data comes from animal models.

• Osteoporosis & Muscle Wasting: A 2009 study by Ligand Pharmaceuticals evaluated LGD-3303 in osteopenic female rats. The study found that LGD-3303 significantly increased bone mineral density, bone formation rate, and muscle mass. Furthermore, when combined with a bisphosphonate (alendronate), the effects on bone were additive, suggesting a potential combination therapy for severe osteoporosis.[6]
• Prostate Sparing: In castrated male rats, LGD-3303 was able to fully restore muscle mass to the level of intact (non-castrated) rats, but it only restored prostate weight to a fraction of the intact level, proving its tissue selectivity.[7]

The Sublingual vs. Oral Debate

In the biohacking community, there is a persistent debate regarding the bioavailability of LGD-3303. Some users claim that oral bioavailability is poor and that the compound must be taken sublingually (held under the tongue for 60 seconds before swallowing) to be effective. However, the preclinical data from Ligand Pharmaceuticals clearly states that LGD-3303 is orally active and was administered via oral gavage in the rat studies. The sublingual requirement is likely a community myth, though sublingual administration may result in faster peak serum concentrations.[8]

Frequently Asked Questions (FAQ).

confidence_tier: community

Q: Is LGD-3303 just a stronger version of LGD-4033? A: No. They are completely different molecules with different effects. LGD-4033 causes significant water retention and is used for bulking. LGD-3303 causes zero water retention and is used for dry mass and cutting.

Q: Why did it never go to human trials? A: Pharmaceutical companies often develop dozens of similar molecules (analogues) simultaneously. Ligand Pharmaceuticals likely chose to advance LGD-4033 into human trials because it showed a slightly better safety or efficacy profile in preclinical models, leaving LGD-3303 abandoned.

Q: Do I have to dose it three times a day? A: Because of its short half-life (~6 hours), dosing it at least twice a day (AM and PM) is highly recommended to keep blood levels stable. Dosing it once a day will result in a massive spike and a rapid crash.

International Regulatory Status.

confidence_tier: well-established

Decision Tree.

confidence_tier: community

[Goal: Dry Muscle Mass and Extreme Muscle Fullness?]
  |
  +-- Are you comfortable using a drug with ZERO human clinical data?
        |
        +-- (No) -> Use Ostarine or LGD-4033 instead.
        |
        +-- (Yes) -> Are you willing to dose multiple times a day?
              |
              +-- (Yes) -> Take 10mg AM and 10mg PM for 6-8 weeks.
                           Take Liver Support (NAC) daily.
                           Follow with 4 weeks of Enclomiphene (PCT).

Schema.org Data.

{
  "@context": "https://schema.org",
  "@type": "MedicalEntity",
  "name": "LGD-3303",
  "description": "A highly potent, non-steroidal selective androgen receptor modulator (SARM) that never progressed past preclinical animal trials. Used off-label in the bodybuilding community for dry muscle mass and strength.",
  "legalStatus": {
    "@type": "DrugLegalStatus",
    "description": "Abandoned investigational drug. Not FDA approved. Banned by WADA."
  }
}

What we cited.